LI YING (GRACE) HUANG

Grace is a director and researcher at the Division of the Health Technology Assessment, Center for Drug Evaluation, Taiwan (CDE/HTA). Before joining CDE/HTA in 2008, Grace worked for 10 years as a clinical pharmacist in a leadership role in department of pharmacy in one of the major medical centers in Taipei. She completed her Ph.D. degree in Graduate Institute of Health Policy and Management, College of Public Health, National Taiwan University and Master’s degree in pharmaceutical science from the National Taiwan University as well. Grace has authored and co-authored articles published in Health Policy, The Journal of Clinical Pharmacology, Journal of Nephrology, European Review for Medical and Pharmacological Sciences, and many others.

She also serves as a reviewer of manuscripts for several international journals. Her current research focuses on comparative efficacy of new drugs, applying mixed treatment comparison methods, patient involved HTA and therapeutic inertia among adult DM patients in Taiwan. Grace is honored to serve as the board of director at INAHTA from 2016 to 2018 and 2019 to present. Grace was also invited as a panelist in HTAi workshop to share the experience of patient involvement in HTA at Taiwan and gain feedback from others.